Medication
Reddy-Sitagliptin and Metformin Hydrochloride
DIN 02540126 · DR Reddy's Laboratories Ltd Likely a generic
What it is
- Active ingredients
- Sitagliptin — 50 mg
- Metformin Hydrochloride — 850 mg
- Form and route
- Tablet · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2023-10-05
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Apo-Sitagliptin-Metformin
- Sandoz Sitagliptin-Metformin
- Apo-Sitagliptin Malate / Metformin Hydrochloride
- Teva-Sitagliptin Malate / Metformin
- Sitagliptin-Metformin
- Auro-Sitagliptin Hydrochloride and Metformin Hydrochloride
- PRZ-Sitagliptin-Metformin
- Jamp Sitagliptin Hydrochloride / Metformin
- AG-Sitagliptin Hydrochloride / Metformin
- Sitagliptin/metformin
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Alimentary tract and metabolism
- ATC code
- A10BD07
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of A10BD07, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.
Search Health Canada recalls for Reddy-Sitagliptin and Metformin Hydrochloride →